Pharma Nord GmbH


Purpose of the company: Manufacturing and sales, including import and export, of food products, supplements, and pharmaceutical products, as well as research related to the mentioned goods and products.

Adress: SchiffbrĂŒckstr. 6 24937 Flensburg Deutschland

Local court: 24937 Flensburg

Register number: HRB3100FL


Free
Credit Report


Total assets

The average total assets of company Pharma Nord GmbH over the last 5 years is 390.694,28 €.

The company Pharma Nord GmbH as of the reporting date 2022 a bank balance of approx. 87.832,86 €. That is 3,91 % more than the average bank balance in the industry of companies with this total assets.


Equity ratio

The equity ratio of Pharma Nord GmbH is 64,73 % in the year 2022. In total, that ist 309.332,58 €.


Balance sheet profit


Change in liquidity compared to previous year

The average absolute change in liquidity of the company Pharma Nord GmbH compared to the previous year amounts to -6.630,09 €. That means that the liquidity of the company has increased or decreased by this amount per year on average.

The cash flow of the company Pharma Nord GmbH amounts to -26.520,36 € in the year 2022.


Publication dates of the annual financial statements

  • 2007: 02.06.2008
  • 2008: 24.06.2009
  • 2009: 30.04.2010
  • 2010: 14.12.2010
  • 2011: 26.07.2012
  • 2012: 23.12.2013
  • 2013: 26.01.2015
  • 2014: 17.03.2016
  • 2015: 16.01.2017
  • 2018: 06.02.2020
  • 2019: 20.07.2020
  • 2020: 25.08.2021
  • 2021: 24.06.2022
  • 2022: 11.10.2023

The publication dates refer to the date on which the company published its annual financial statements in the company register. This information can provide important insights into the management of the company.


Source and reliability of the data

The information presented here comes from publicly accessible sources, in particular the Unternehmensregister, in which companies are obliged to disclose their annual financial statements (Sections 325 et seq. of the German Commercial Code (HGB)).

All key financial figures are based on the companies' published annual financial statements. The information is analysed automatically by Bonscore, without content processing or interpretation.

Please note that despite the utmost care, no guarantee can be given that the information provided is up-to-date, complete or correct.